By: Steve Schneible From: aacr.org What does it mean when we say that women in the United States face a 13% lifetime risk of developing breast cancer? According to the National Cancer Institute (NCI), that lifetime risk can be thought of as the likelihood that a woman born in the United States today will develop breast cancer at some point …
NIH researchers discover tissue biomarker that may indicate higher risk of aggressive breast cancer development and death
Source: National Cancer Institute From: cancer.gov What Researchers at the National Institutes of Health (NIH) have identified a series of changes in the architecture and cell composition of connective tissues of the breast, known as stromal tissue, that is associated with an increased risk of developing aggressive breast cancer among women with benign breast disease, and poorer rates of survival …
Common Cancer Myths and Misconceptions
Source: National Cancer Institute From: cancer.gov Certain popular ideas about how cancer starts and spreads—though scientifically wrong—can seem to make sense, especially when those ideas are rooted in old theories. But wrong ideas about cancer can lead to needless worry and even hinder good prevention and treatment decisions. This page provides the latest science-based information about some common cancer myths …
Unexpected Findings on Weight Loss and Breast Cancer from International Study in JNCCN
Source: National Comprehensive Cancer Network From: prnewswire.com New research in the February 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network examined body mass index (BMI) data for people with HER2-positive early breast cancer, and found a 5% weight loss in patients over two years in was associated with worse outcomes. Weight gain over the same time period did not …
After 48 Years, NCI Aims to Track Breast Cancer Recurrences
By: Nick Mulcahy From: medscape.com Change to SEER Eventually Planned Patients with breast cancer want accurate information on the risk of their cancer recurring once they have completed treatment. “I would like to know the true stats of how many breast cancers come back no matter what the hell we do for treatment,” comments a typical post on a breast …
Regular aspirin use can lower risk for death in bladder, breast cancers
By: Brian P. Dunleavy From: upi.com People who take aspirin at least three times per week are more likely to survive bladder cancer, according to an analysis published Friday by JAMA Network Open. Regular aspirin use also was associated with a reduced risk for death from breast cancer, the data showed. However, taking aspirin had no effect on a person’s …
Preventing brain metastasis in breast cancer
By: Diane Mapes, Fred Hutch News Service From: redhutch.org Translational researcher Dr. Cyrus Ghajar of Fred Hutchinson Cancer Research Center received nearly $2.4 million from the National Cancer Institute for a five-year study designed to develop strategies to prevent brain metastasis in breast cancer patients. Ghajar, who joined the Hutch in 2014, studies breast cancer metastasis, particularly the tiny seeds …
The Bone-Building Blueprint For Better Health After Treatment for Cancer
By: Marilyn Fenichel From: curetoday.com When Lance Ferderer, 72, of Silver Spring, Maryland, received his first biopsy confirming that he had prostate cancer in 2016, he was told low-risk cancer could be monitored through active surveillance. But he didn’t remain in that protocol for long. “I was persuaded by my primary care physician to sign up for a clinical trial …
Off Target: Investigating the Abscopal Effect as a Treatment for Cancer
Source: National Cancer Institute From: cancer.gov The patient had run out of treatment options. Her cancer, a rare form of sarcoma, had metastasized and was no longer responding to therapies. As a next step, doctors at the Washington University School of Medicine in St. Louis began to treat her largest tumor with proton beam radiation. The goals were to slow …
Cancer patients find clinical trials, hope and help
By: Diane Mapes From: fredhutch.org #NWMetsConf connects metastatic breast cancer patients with trials, treatments, tools and each other Clinical trials — the treatments of tomorrow, today — took top billing at the fourth annual Northwest Metastatic Breast Cancer Conference held Saturday at the Amazon Meeting Center in Seattle. Scientists from Fred Hutchinson Cancer Research Center shared new treatments; National Cancer …